Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-03-09 @ 7:17 AM
Study NCT ID:
NCT02509494
Status:
COMPLETED
Last Update Posted:
2022-07-18
First Post:
2015-06-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo
Sponsor:
Janssen Vaccines & Prevention B.V.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR107372
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None